Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Iovance Biotherapeutics Q4 EPS $(0.45) Misses $(0.43) Estimate, Sales $482.00K

Author: Benzinga Newsdesk | February 28, 2024 05:06pm
Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 29.69 percent increase over losses of $(0.64) per share from the same period last year. The company reported $482.00 thousand in sales this quarter.

Posted In: IOVA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist